Fny Investment Advisers, LLC Krystal Biotech, Inc. Transaction History

Fny Investment Advisers, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 12, 2021	SELL	$59.42 - $85.46 $1.26 Million - $1.81 Million	-21,148 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$40.64 - $61.38 $406,400 - $613,800	10,000 Added 89.7%	21,148 $1.27 Million
Q3 2020 Oct 09, 2020	BUY	$37.76 - $48.49 $420,948 - $540,566	11,148 New	11,148 $479,000

311

24.4M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.99B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.